Cleared Traditional

K915075 - NEBULIZER (DIRECT PATIENT INTERFACE)

K915075 is an FDA 510(k) clearance for NEBULIZER (DIRECT PATIENT INTERFACE), manufactured by Medi Nuclear Corp., Inc.. The device is a Class 2 Anesthesiology device with product code CAF cleared through the Traditional 510(k) pathway after a 251-day FDA review.

K915075 · Medi Nuclear Corp., Inc. · Anesthesiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jul 1992
Decision
251d
Days
Class 2
Risk

K915075 is an FDA 510(k) clearance for the NEBULIZER (DIRECT PATIENT INTERFACE). Classified as Nebulizer (direct Patient Interface) (product code CAF), Class II - Special Controls.

Submitted by Medi Nuclear Corp., Inc. (Baldwin Park, US). The FDA issued a Cleared decision on July 16, 1992 after a review of 251 days - an extended review cycle.

This device falls under the Anesthesiology FDA review panel, regulated under 21 CFR 868.5630 - the FDA anesthesiology and respiratory device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Anesthesiology review framework, consistent with the majority of Class II 510(k) submissions.

View all Medi Nuclear Corp., Inc. devices

FDA 510(k) Submission Details - K915075

510(k) Number K915075 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received November 08, 1991
Decision Date July 16, 1992
Days to Decision 251 days
Submission Type Traditional
Review Panel Anesthesiology (AN)
Summary Statement
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
111d slower than avg
Panel avg: 140d · This submission: 251d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

CAF Device Classification - Class 2, Special Controls

Product Code CAF Nebulizer (direct Patient Interface)
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 868.5630
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Anesthesiology devices follow this clearance model.

Regulatory Peers - CAF Nebulizer (direct Patient Interface)

All 199
Devices cleared under the same product code (CAF) and FDA review panel - the closest regulatory comparables to K915075.
HEART NEBULIZER
K923596 · Vortran Medical Technology 1, Inc. · Oct 1992
NE-U07
K922923 · Omron Healthcare, Inc. · Sep 1992
NE-U04/NE U04F
K923024 · Omron Healthcare, Inc. · Sep 1992
MININEB
K920443 · Vortran Medical Technology 1, Inc. · Jul 1992
HEART NUBULIZER
K920332 · Vortran Medical Technology 1, Inc. · May 1992
OMRON COMPRESSOR NEBULIZER- MODEL NE-C09
K914836 · Omron Healthcare, Inc. · May 1992